B
Baird Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
CLLS
851
Cellectis
CLLS
$269M
|
MK
Madhu Kumar
| $2.68 | $39 |
1,355%
upside
| Outperform |
16 Mar ‘21
4 years ago |
|
852
Voyager Therapeutics
VYGR
$235M
|
BS
Brian Skorney
| $4.24 | $6 |
42%
upside
| Neutral |
26 Feb ‘21
4 years ago |
|
853
Hologic
HOLX
$14.8B
|
RZ
Ryan Zimmerman
| $66.76 | $91 |
36%
upside
| Buy |
22 Feb ‘21
4 years ago |
|
854
Mid-America Apartment Communities
MAA
$17B
|
AS
Amanda Sweitzer
| $145.40 | $137 |
6%
downside
| Neutral |
9 Feb ‘21
4 years ago |
|
855
Camden Property Trust
CPT
$11.9B
|
AS
Amanda Sweitzer
| $111.36 | $109 |
2%
downside
| Outperform |
9 Feb ‘21
4 years ago |
|
856
Equity Lifestyle Properties
ELS
$12B
|
RM
RJ Milligan
| $61.72 | $67 |
9%
upside
| Outperform |
20 Jan ‘21
4 years ago |
|
857
Sotera Health
SHC
$4.44B
|
MP
Mike Polark
| $15.62 | $31 |
98%
upside
| Outperform |
14 Jan ‘21
4 years ago |
|
858
Norfolk Southern
NSC
$62.3B
|
BH
Benjamin Hartford
| $277.75 | $286 |
3%
upside
| Outperform |
13 Jan ‘21
4 years ago |
|
859
Landstar System
LSTR
$4.58B
|
BH
Benjamin Hartford
| $132.08 | $164 |
24%
upside
| Outperform |
13 Jan ‘21
4 years ago |
|
860
Regions Financial
RF
$24.1B
|
DG
David George
| $27.03 | $17 |
37%
downside
| Neutral |
7 Jan ‘21
4 years ago |
|
861
Kilroy Realty
KRC
$5.05B
|
DR
Dave Rodgers
| $42.70 | $65 |
52%
upside
| Outperform |
7 Jan ‘21
4 years ago |
|
862
Highwoods Properties
HIW
$3.44B
|
DR
Dave Rodgers
| $31.85 | $40 |
26%
upside
| Neutral |
7 Jan ‘21
4 years ago |
|
863
Douglas Emmett
DEI
$2.83B
|
DR
David Rodgers
| $16.91 | $29 |
72%
upside
| Neutral |
7 Jan ‘21
4 years ago |
|
864
Alexandria Real Estate Equities
ARE
$14.5B
|
DR
Dave Rodgers
| $84.70 | $194 |
129%
upside
| Outperform |
7 Jan ‘21
4 years ago |
|
865
Welltower
WELL
$112B
|
DR
Dave Rodgers
| $167.82 | $68 |
59%
downside
| Outperform |
6 Jan ‘21
4 years ago |
|
866
Arcturus Therapeutics
ARCT
$485M
|
MK
Madhu Kumar
| $17.85 | $69 |
287%
upside
| Neutral |
29 Dec ‘20
4 years ago |
|
|
XYZ
867
Block, Inc.
XYZ
$45.7B
| $74.94 | $245 |
227%
upside
| Neutral |
23 Dec ‘20
4 years ago |
|
|
868
Qualcomm
QCOM
$172B
| $159.84 | $200 |
25%
upside
| Outperform |
23 Dec ‘20
4 years ago |
|
|
869
Maravai LifeSciences
MRVI
$363M
| $2.51 | $31 |
1,135%
upside
| Outperform |
15 Dec ‘20
4 years ago |
|
|
870
Leslie's
LESL
$64.6M
| $0.3478 | $25 |
7,088%
upside
| Outperform |
23 Nov ‘20
4 years ago |
|
|
871
Editas Medicine
EDIT
$248M
|
MK
Madhu Kumar
| $2.76 | $14 |
407%
upside
| Underperform |
3 Nov ‘20
4 years ago |
|
872
CalciMedica
CALC
$43M
|
CR
Christopher Raymond
| $3.08 | $378 |
12,173%
upside
| Overweight |
20 Oct ‘20
4 years ago |
|
873
Carvana
CVNA
$50.9B
|
AP
Alexander Potter
| $368.88 | $260 |
30%
downside
| Overweight |
20 Oct ‘20
4 years ago |
|
874
Simmons First National
SFNC
$3.02B
| $20.88 | $21 |
1%
upside
| Neutral |
20 Oct ‘20
4 years ago |
|
|
875
Visteon
VC
$3.41B
| $125.13 | $100 |
20%
downside
| Outperform |
20 Oct ‘20
4 years ago |
|